After confirmation of transduction by flow cytometry for hCD40L (94%) and IL-2 secretion (2,412 pg/ml/106 leukemic cells), the gene-modified tumor vaccine was irradiated (30 Gy) and cryopreserved. This evidence concerns the gene IL2 and neoplasm.